PRESS RELEASE published on 09/16/2024 at 07:00, 2 years 2 months ago Curatis: Deutlich gesteigerter Umsatz im Kerngeschäft und Projekte in Entwicklungs-Pipeline auf Kurs Curatis Holding AG reports significantly increased revenue in core business and projects in development pipeline on track. Strong financial position and growth prospects highlighted in H1 2024 results Financial Results Pharmaceutical Industry Revenue Business Development Curatis Holding AG
BRIEF published on 09/12/2024 at 19:51, 2 years 2 months ago Curatis Holding AG présentera ses résultats du premier semestre à Investora Rapport Semestriel Soumission À La FDA Médicaments Orphelins Curatis Holding Conférence Investora
BRIEF published on 09/12/2024 at 19:51, 2 years 2 months ago Curatis Holding AG to Present at Investora and Release H1 Report Early Half-year Report Orphan Drugs FDA Submission Curatis Holding Investora Conference
PRESS RELEASE published on 09/12/2024 at 19:46, 2 years 2 months ago Teilnahme an der Investora am 19. September 2024 und frühere Publikation des Halbjahresreports am 16. September Curatis Holding to participate in Investora on September 19, 2024, and release half-year report on September 16. Key executives to present the company at the conference Conference Orphan Drugs Pharma Curatis Holding Investora
BRIEF published on 08/27/2024 at 17:50, 2 years 2 months ago Curatis sur la bonne voie : soumet une demande d'autorisation de mise sur le marché de médicaments orphelins pour un produit candidat clé aux États-Unis Curatis Médicament Orphelin La FDA Tumeur Cérébrale Pédiatrique
BRIEF published on 08/27/2024 at 17:50, 2 years 2 months ago Curatis on Track: Submits Orphan Drug Application for Key Product Candidate in the US FDA Curatis Orphan Drug Brain Tumor Pediatric
PRESS RELEASE published on 08/27/2024 at 17:45, 2 years 2 months ago Curatis auf Kurs: Einreichung des Antrags für Orphan-Drug-Designation des wichtigsten Produktkandidaten in den USA Curatis Holding AG submits application for Orphan Drug Designation of lead product candidate C-PBTE-01 in the USA, targeting rare brain tumors affecting children Orphan Drug Designation Rare Disease Curatis Holding AG C-PBTE-01 Childhood Cancer
BRIEF published on 07/25/2024 at 07:05, 2 years 3 months ago Curatis Holding AG : Initiation de la couverture par valuationLAB Curatis Recherche Sur Les Actions C-PTBE-01 ÉvaluationLAB Médicaments Orphelins
BRIEF published on 07/25/2024 at 07:05, 2 years 3 months ago Curatis Holding AG: Initiation of Coverage by valuationLAB Curatis Equity Research Orphan Drugs ValuationLAB C-PTBE-01
PRESS RELEASE published on 07/25/2024 at 07:00, 2 years 3 months ago Curatis Holding AG: Initiation of Coverage and Publication of Equity Research Report by valuationLAB Curatis Holding AG has initiated coverage and published an equity research report by valuationLAB estimating a risk-adjusted net present value of CHF 20.00 per share, signaling an enterprise value of CHF 103 million Initiation Of Coverage Curatis Holding AG ValuationLAB Equity Research Report CHF 20.00 Per Share
Published on 11/19/2026 at 14:30, 15 minutes ago Boron One Reports Metallurgical Study Results and Identifies Preferred Concentration Process for Third-Party Borate Materials
Published on 11/19/2026 at 14:30, 15 minutes ago Vogenx Set to Join the Russell 2000(R), Russell 3000(R), and Russell Microcap(R) Indexes
Published on 11/19/2026 at 14:00, 45 minutes ago QNX Brings Physical AI and Next-Generation Software-Defined Vehicle Innovation to CES 2027
Published on 11/19/2026 at 13:45, 1 hour ago Karbon-X (OTCQB:KARX) Enters California's Multi-Billion-Dollar Compliance Carbon Market Following CITSS Approval
Published on 11/19/2026 at 13:30, 1 hour 15 minutes ago ROK Resources Files Financial Results and Management Discussion & Analysis for Third Quarter of 2026
Published on 11/19/2026 at 14:30, 15 minutes ago ADS-TEC Energy Secures Repeat Order from German Utility SWLB for Large-Scale Battery Storage Systems
Published on 11/19/2026 at 14:00, 45 minutes ago MALAYSIA HAND OVER A LETTER OF INTENT TO KNDS FOR THE PROCUREMENT OF ARTILLERY 105MM LIGHT GUN SYSTEMS
Published on 11/19/2026 at 14:00, 45 minutes ago LA MALAISIE REMET A KNDS UNE LETTRE D’INTENTION POUR L’ACQUISITION DE 36 SYSTÈMES D’ARTILLERIE LÉGÈRE 105LG
Published on 11/19/2026 at 13:45, 1 hour ago Moody’s Ratings raises outlook for Fresenius to positive from stable
Published on 11/19/2026 at 08:30, 6 hours 15 minutes ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing
Published on 11/19/2026 at 08:30, 6 hours 15 minutes ago Souveraineté des données : Cegedim ouvre EB6, un datacenter nouvelle génération pour l'IA et la haute densité
Published on 11/19/2026 at 08:00, 6 hours 45 minutes ago EXOR VA RENFORCER SA PARTICIPATION DANS BIOMÉRIEUX
Published on 11/19/2026 at 07:30, 7 hours 15 minutes ago Gimv investeert in SpiraTec, specialist in automatisering en digitale transformatie in de procesindustrie